Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 10;11(7):839.
doi: 10.3390/children11070839.

Comparison of Metabolic Control in Children and Adolescents Treated with Insulin Pumps

Agnieszka Lejk  1 , Karolina Myśliwiec  1 , Arkadiusz Michalak  2   3 , Barbara Pernak  2 , Wojciech Fendler  2 , Małgorzata Myśliwiec  1
Affiliations

Comparison of Metabolic Control in Children and Adolescents Treated with Insulin Pumps

Agnieszka Lejk et al. Children (Basel). .

Abstract

Background: While insulin pumps remain the most common form of therapy for youths with type 1 diabetes (T1DM), they differ in the extent to which they utilize data from continuous glucose monitoring (CGM) and automate insulin delivery.

Methods: The aim of the study was to compare metabolic control in patients using different models of insulin pumps. This retrospective single-center study randomly sampled 30 patients for each of the following treatments: Medtronic 720G without PLGS (predictive low glucose suspend), Medtronic 640G or 740G with PLGS and Medtronic 780G. In the whole study group, we used CGM systems to assess patients' metabolic control, and we collected lipid profiles. In three groups of patients, we utilized CGM sensors (Guardian 3, Guardian 4, Libre 2 and Dexcom G6) to measure the following glycemic variability proxy values: time in range (TIR), time below 70 mg/dL (TBR), time above 180 mg/dL (TAR), coefficient of variation (CV) and mean sensor glucose.

Results: Medtronic 640G or 740G and 780G users were more likely to achieve a target time in the target range 70-180 mg/dL (≥80%) [Medtronic 720G = 4 users (13.3%) vs. Medtronic 640G/740G = 10 users (33.3%) vs. Medtronic 780G = 13 users (43.3%); p = 0.0357)] or low glucose variability [Medtronic 720G = 9 users (30%) vs. Medtronic 640G/740G = 18 users (60%) vs. Medtronic 780G = 19 users (63.3%); p = 0.0175)].

Conclusions: Any integration between the insulin pump and CGM was associated with better glycemic control. More advanced technologies and artificial intelligence in diabetes help patients maintain better glycemia by eliminating various factors affecting postprandial glycemia.

Keywords: closed loop; insulin pump; predictive suspend.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Time in range for 720G, 640G/740G and 780G; (b) time below range for 720G, 640G/740G and 780G; (c) time above range for 720G, 640G/740G and 780G; (d) coefficient of variation for glucose for 720G, 640G/740G and 780G. #, $ denote significant (p < 0.05) pair-wise comparisons in post hoc tests.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Position of the Polish Diabetes Association Current Topics in Diabetes 2024. Curr. Top Diabetes. 2023;3:1–348. doi: 10.5114/ctd/183052. - DOI
    1. Stephan Y., Sutin A.R., Luchetti M., Canada B., Terracciano A. Personality and HbA1c: Findings from six samples. Psychoneuroendocrinology. 2020;120:104782. doi: 10.1016/j.psyneuen.2020.104782. - DOI - PMC - PubMed
    1. Niemiec A., Juruć A., Moleda P., Safranow K., Majkowska L. Personality traits, metabolic control and the use of insulin pump functions in adults with Type 1 diabetes: An observational single visit study. Diabetes Ther. 2021;12:419–430. doi: 10.1007/s13300-020-00974-z. - DOI - PMC - PubMed
    1. Beck R.W., Raghinaru D., Calhoun P., Bergenstal R.M. A comparison of continuous glucose monitoring-measured time-in-range 70–180 mg/dL versus time-in-tight-range 70–140 mg/dL. Diabetes Technol. Ther. 2024;26:151–155. doi: 10.1089/dia.2023.0380. - DOI - PubMed
    1. Castaneda J., Arrieta A., Heuvel T.V.D., Cohen O. The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system. Diabetes Obes. Metab. 2023;25:2545–2552. doi: 10.1111/dom.15139. - DOI - PubMed

LinkOut - more resources